Marginal means – Pooled across scenarios. by Mehdi Mourali (10170245)

Quantitative antibody and antigen responses to nMAb vs placebo day 1-90: Pooled analysis of neutralizing monoclonal antibodies. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses after treatment with nMAb vs placebo, day 1-90 (pooled nMAb treatments). by Elizabeth S. Munroe (21568166)

Subjects:

Description of the treatment pool in multidisciplinary rehabilitation. by Marina Kuzdas-Sallaberger (12291278)

One-dimensional data pooling operation diagram. by Hongwei Bai (1447999)

Meta-analyses estimating the pooled mean diarrhea prevalence in children under 5 years of age in countries with available DHS, for each WHO region and globally. by Zahir M. Tag (21820157)

Forest plot of the pooled analysis showing subjective sleep score on the first night after surgery. by Lin Wang (11986)

Spatial and temporal variation of the mean abundance of adult corals at the 10 stations located on the three major habitats, for the five categories (all taxa pooled, Acroporidae,... by Radonirina Lebely Botosoamananto (13989736)

Spatial and temporal variation of the mean abundance of juvenile corals at the 10 stations located on the three major habitats, for the five categories (all taxa pooled, Acroporida... by Radonirina Lebely Botosoamananto (13989736)

Spatial and temporal variation of the mean abundance of coral recruits at the 10 stations located on the three major habitats, for the five categories (all taxa pooled, Acroporidae... by Radonirina Lebely Botosoamananto (13989736)

Boxplot comparing Ct values for HD in flies and clothes. by Philippe Ndzomo (17706039)

The relative contribution of geographic position, climate conditions (mean annual air temperature, precipitation and radiation), soil conditions (mean soil organic carbon, total ni... by Guangyu Zhang (146127)

Univariate linear regression analysis of caloric intake in relation to mean differences in weight loss. by Duc Tran Quang (20564967)

Antibody and antigen responses to Lufotrelvir vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Sotrovimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to nMAb vs placebo day 1–90 for Amubarvimab/ Romlusevimab. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses to Ensovibep vs placebo day 1–90. by Elizabeth S. Munroe (21568166)

Subjects:

Long-term anti-nucleocapsid response by baseline patient characteristics. by Elizabeth S. Munroe (21568166)

Subjects:

Antibody and antigen responses by baseline anti-spike neutralizing response assay positivity. by Elizabeth S. Munroe (21568166)

Subjects:

Baseline patient characteristics across neutralizing monoclonal antibody trials. by Elizabeth S. Munroe (21568166)

Subjects: